Multiple Myeloma
Showing NaN - NaN of 40
Multiple Myeloma Trial in Worldwide (Bortezomib, Melphalan, Prednisone (VMP), 1 or 2 cycle(s) HDM (High Dose Melphalan), 2
Active, not recruiting
- Multiple Myeloma
- Bortezomib, Melphalan, Prednisone (VMP)
- +2 more
-
Brisbane, Australia
- +207 more
Mar 22, 2021
Irradiated Bone Marrow, Transplant-Related Hematologic Malignancy, Leukemia, Acute Trial in Milano (Conditioning treatment
Terminated
- Irradiated Bone Marrow
- +4 more
- Conditioning treatment "Treosulfan-TMI"
- +2 more
-
Milano, Lombardia, ItalyOspedale San Raffaele
Oct 13, 2020
Multiple Myeloma Trial in Worldwide (Lenalidomide and low-dose dexamethasone, Lenalidomide plus low-dose dexamethasone given for
Completed
- Multiple Myeloma
- Lenalidomide and low-dose dexamethasone
- +2 more
-
Birmingham, Alabama
- +287 more
Nov 7, 2019
Multiple Myeloma Trial in Worldwide (CC-5013 plus dexamethasone, Dexamethasone plus Placebo)
Completed
- Multiple Myeloma
- CC-5013 plus dexamethasone
- Dexamethasone plus Placebo
-
Camperdown, New South Wales, Australia
- +68 more
Sep 18, 2017
Multiple Myeloma Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo, Bortezomib)
Withdrawn
- Multiple Myeloma
- Radium-223 dichloride (Xofigo, BAY88-8223)
- +3 more
-
Scottsdale, Arizona
- +57 more
Oct 6, 2016
Multiple Myeloma Trial in Worldwide (A (Thalidomide + Dexamethasone), B (Placebo + Dexamethasone))
Completed
- Multiple Myeloma
- A (Thalidomide + Dexamethasone)
- B (Placebo + Dexamethasone)
-
Hoover, Alabama
- +98 more
Sep 9, 2015
Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndrome Trial in Italy (Treosulfan IV)
Unknown status
- Leukemia
- +6 more
- Treosulfan IV
-
San Giovanni Rotondo, Foggia, Italy
- +11 more
Aug 10, 2009